Coronavirus: no long immunity. Ill with COVID-19 lose antibodies – Koch Institute – Ukrainian news, World


According to doctors from Munich, in four out of nine patients treated in January, the number of antibodies decreases

The immunity that protects against recurrence of illness in patients with coronavirus may be short-lived, so no one should feel safe. This is evidenced by a survey conducted by scientists of the Robert Koch Institute (RKI), which was told by RKI President Lothar Wheeler, reports Ukrinform.

Read us in Telegram: verified facts, only important

It is noted that in those who have already had COVID-19, the level of antibodies decreases quite quickly.

“In four of the nine patients treated in January, we see a decrease in neutralizing antibodies,” said Clemens Wendtner, head physician at the Munich Infectious Disease Clinic.

It is reported that this allegedly indicates that immunity to the new coronavirus is short-lived. The likelihood of reinfection over time becomes “high enough,” says the president of RKI.

“The first results of a study of antibodies to the virus among blood donors showed low immunity in the examined,” said the president of RKI.

He noted that 12,000 people were tested, and antibodies were found in only 1.3% of them. This interim result indicates, on the one hand, that most people in Germany have obviously not yet been in contact with the virus, but on the other the virus can still spread widely.

  • Belgian scientists have created a vaccine YF-S0 against a new coronavirus based on a weakened and genetically modified yellow fever virus. On successful trials of the drug in mice and hamsters, they reported in preprints on bioRxiv servers.
  • For a day, July 12, in the world recorded at least 230,370 patients with coronavirus disease COVID-19. According to the WHO, this is a record daily incidence rate for the entire pandemic.

Natalia Medvedeva

If you notice a spelling error, select it with the mouse and press Ctrl + Enter.


Please enter your comment!
Please enter your name here